Stay updated with breaking news from Infobionic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Fourth Quarter 2023 Net Investment Income per Share of $0.45; NAV per Share of $9.71 - - Annual Debt Portfolio Yield of 16.6% - - HRZN Ends Year with Committed Backlog of $218 Million - - Declares...
/PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), an affiliate of Monroe Capital, and a leading specialty finance company that...
The use of artificial intelligence (AI) to advance stem cell therapy has produced exciting results, with a key role in driving recent growth and innovation. Separated into three parts,...
InfoBionic, the virtual telemetry company focused on efficiency and economics of cardiac remote patient monitoring, announces FDA 510(k) clearance for its MoMe ARC solution that encompasses our next generation remote ECG monitoring device and initial Bluetooth diagnostic 6-lead sensor designed to aid physicians in their diagnosis of cardiac arrhythmias.
In a patent case involving claims directed to train-traffic-control systems, Judge Failla of the Southern District of New York denied Defendant Amtrak’s motion to dismiss, rejecting...